Gene transfer into rat mesenchymal stem cells: A comparative study of viral and nonviral vectors

Stem Cells and Development

Volumn 15, Issue 1, 2006, Pages 87-96

  Mcmahon, J M ^a   Conroy, S ^a   Lyons, M ^a   Greiser, U ^a   O'Shea, C ^a   Strappe, P ^a   Howard, L ^a   Murphy, M ^a   Barry, F ^a   O'Brien, Tim ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA;

ADENOVIRUS VECTOR; ADIPOCYTE; ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CONTROLLED STUDY; ELECTROPORATION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; INTERMETHOD COMPARISON; LENTIVIRUS VECTOR; MESENCHYMAL STEM CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARAMETER; PARVOVIRUS 1 VECTOR; PARVOVIRUS 2 VECTOR; PARVOVIRUS 4 VECTOR; PARVOVIRUS 5 VECTOR; PARVOVIRUS 6 VECTOR; PARVOVIRUS VECTOR; PRIORITY JOURNAL; RABBIT; RAT; SEROTYPE; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TISSUE REPAIR; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS STRAIN; VIRUS TITRATION; VIRUS VECTOR;

ADENOVIRIDAE; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL SURVIVAL; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; LENTIVIRUS; MESENCHYMAL STEM CELLS; RABBITS; RATS; RATS, INBRED F344; TRANSFECTION;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; ANIMALIA; LENTIVIRUS; ORYCTOLAGUS CUNICULUS; PARVOVIRUS;

EID: 33645392225     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2006.15.87     Document Type: Article

References (61)

1. Barry F, RE Boynton, B Liu and JM Murphy. (2001). Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation- dependent gene expression of matrix components. Exp Cell Res 268:189-200.
2. Digirolamo CM, D Stokes, D Colter, DG Phinney, R Class and DJ Prockop. (1999). Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107:275-281.
3. Friedenstein AJ, RK Chailakhyan and UV Gerasimov. (1987). Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tiss Kinet 20:263-272.
4. Johnstone B, TM Hering, AI Caplan, VM Goldberg and JU Yoo. (1998). In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238:265-272.
5. Muraglia A, R Cancedda and R Quarto. (2000). Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113 (Pt 7):1161-1166.
6. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
7. Noth U, AM Osyczka, R Tuli, NJ Hickok, KG Danielson and RS Tuan. (2002). Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 20:1060-1089.
8. Tuli R, MR Seghatoleslami, S Tuli, ML Wang, WJ Hozack, PA Manner et al. (2003). A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone. Mol Biotechnol 23:37-49.
9. Zuk PA, M Zhu, P Ashjian, DA De Ugarte, JI Huang, H Mizuno, et al. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295.
10. Kuznetsov SA, MH Mankani, S Gronthos, K Satomura, P Bianco and PG Robey. (2001). Circulating skeletal stem cells. J Cell Biol 153:1133-1140.
11. Rosada C, J Justesen, D Melsvik, P Ebbesen and M Kassem. (2003). The human umbilical cord blood: a potential source for osteoblast progenitor cells. Calcif Tissue Int 72:135-142.
12. De Bari C, F Dell'Accio, P Tylzanowski and FP Luyten. (2001). Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44:1928-1942.
13. Miura M, S Gronthos, M Zhao, B Lu, LW Fisher, PG Robey et al. (2003). SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A 100:5807-5812.
14. Barry FP and JM Murphy. (2004). Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36:568-584.
15. Barry FP, JM Murphy, K English and BP Mahon. (2005). Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft. Stem Cells Dev 14:252-265.
16. Ryan JM, FP Barry, JM Murphy and BP Mahon. (2005). Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2:8.
17. Bruder SP, N Jaiswal, NS Ricalton, JD Mosca, KH Kraus and S Kadiyala. (1998). Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res (355 Suppl):S247-S256.
18. Devine SM, AM Bartholomew, N Mahmud, M Nelson, S Paul, W Hardy et al. (2001). Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 29:244-255.
19. Ponticiello MS, RM Schinagl, S Kadiyala and FP Barry. (2000). Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. J Biomed Mater Res 52:246-255.
20. Lieberman JR, LQ Le, L Wu, GA Finerman, A Berk, ON Witte et al. (1998). Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res 16:330-339.
21. Lou J, F Xu, K Merkel and P Manske. (1999). Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J Orthop Res 17:43-50.
22. Musgrave DS, P Bosch, S Ghivizzani, PD Robbins, CH Evans and J Huard. (1999). Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 24:541-547.
23. Peterson B, J Zhang, R Iglesias, M Kabo, M Hedrick, P Benhaim et al. (2005). Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 11:120-129.
24. van Tuyn J, S Knaan-Shanzer, MJ van de Watering, M de Graaf, A van der Laarse, MJ Schalij et al. (2005). Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin. Cardiovasc Res 67(2):245-255.
25. Lee CI, DB Kohn, JE Ekert and AF Tarantal. (2004). Morphological analysis and lentiviral transduction of fetal monkey bone marrow-derived mesenchymal stem cells. Mol Ther 9:112-123.
26. Totsugawa T, N Kobayashi, T Okitsu, H Noguchi, T Watanabe, T Matsumura et al. (2002). Lentiviral transfer of the LacZ gene into human endothelial cells and human bone marrow mesenchymal stem cells. Cell Transplant 11:481-488.
27. Zhang XY, VF La Russa and J Reiser. (2004). Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins. J Virol 78:1219-1229.
28. Ju XD, SQ Lou, WG Wang, JQ Peng and H Tian. (2004). Effect of hydroxyurea and etoposide on transduction of human bone marrow mesenchymal stem and progenitor cell by adeno-associated virus vectors. Acta Pharmacol Sin 25:196-202.
29. Kumar S, G Mahendra, TR Nagy and S Ponnazhagan. (2004). Osteogenic differentiation of recombinant adeno-associated virus 2-transduced murine mesenchymal stem cells and development of an immunocompetent mouse model for ex vivo osteoporosis gene therapy. Hum Gene Ther 15:1197-1206.
30. Lu L, C Zhao, Y Liu, X Sun, C Duan, M Ji et al. (2005). Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease. Brain Res Brain Res Protoc 15:46-51.
31. Byun HM, D Suh, Y Jeong, HS Wee, JM Kim, WK Kim et al. (2005). Plasmid vectors harboring cellular promoters can induce prolonged gene expression in hematopoietic and mesenchymal progenitor cells. Biochem Biophys Res Commun 332:518-523.
32. Haleem-Smith H, A Derfoul, C Okafor, R Tuli, D Olsen, DJ Hall et al. (2005). Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol Biotechnol 30:9-20.
33. Moutsatsos IK, G Turgeman, S Zhou, BG Kurkalli, G Pelled, L Tzur et al. (2001). Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 3:449-461.
34. Park J, J Ries, K Gelse, F Kloss, K von der Mark, J Wiltfang et al. (2003). Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther 10:1089-1098.
35. Song L, L Chau, Y Sakamoto, J Nakashima, M Koide and RS Tuan. (2004). Electric field-induced molecular vibration for noninvasive, high-efficiency DNA transfection. Mol Ther 9:607-616.
36. Jaquet K, KT Krause, J Denschel, P Faessler, M Nauerz, S Geidel et al. (2005). Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism? Stem Cells Dev 14:299-309.
37. Iwase T, N Nagaya, T Fujii, T Itoh, S Murakami, T Matsumoto et al. (2005). Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res 66:543-551.
38. Kurozumi K, K Nakamura, T Tamiya, Y Kawano, K Ishii, M Kobune et al. (2005). Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 11:96-104.
39. Kurozumi K, K Nakamura, T Tamiya, Y Kawano, M Kobune, S Hirai et al. (2004). BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther 9:189-197.
40. Tohill M, C Mantovani, M Wiberg and G Terenghi. (2004). Rat bone marrow mesenchymal stem cells express glial markers and stimulate nerve regeneration. Neurosci Lett 362:200-203.
41. Lennon DP, SE Haynesworth, RG Young, JE Dennis and AI Caplan. (1995). A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp Cell Res 219:211-222.
42. Neuhuber B, G Gallo, L Howard, L Kostura, A Mackay and I Fischer. (2004). Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. J Neurosci Res 77: 192-204.
43. Carlson CA, DM Shayakhmetov and A Lieber. (2002). Restoration of a functional open reading frame by homologous recombination between two adenoviral vectors. Mol Ther 6:99-105.
44. Grimm D and MA Kay. (2003). From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr Gene Ther 3:281-304.
45. Zolotukhin S, M Potter, I Zolotukhin, Y Sakai, S Loiler, TJ Fraites Jr. et al. (2002). Production and purification of serotype l, 2, and 5 recombinant adeno-associated viral vectors. Methods 28:158-167.
46. Philpott NJ, AJ Turner, J Scopes, M Westby, JC Marsh, EC Gordon-Smith et al. (1996). The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood 87:2244-2251.
47. Beyth S, Z Borovsky, D Mevorach, M Liebergall, Z Gazit, H Asian et al. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214-2219.
48. Klyushnenkova E, JD Mosca, V Zernetkina, MK Majumdar, KJ Beggs, DW Simonetti et al. (2005). T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 12:47-57.
49. Guenechea G, OI Gan, T Inamitsu, C Dorrell, DS Pereira, M Kelly et al. (2000). Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-re-populating cells with third-generation lentiviral vectors. Mol Ther 1:566-573.
50. Zhang XY, VF La Russa, L Bao, J Kolls, P Schwarzenberger and J Reiser. (2002). Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. Mol Ther 5(5 Pt 1):555-565.
51. Anjos-Afonso F, EK Siapati and D Bonnet. (2004). In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 117(Pt23):5655-5664.
52. Sugiyama O, DS An, SP Kung, BT Feeley, S Gamradt, NQ Liu et al. (2005). Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther 11:390-398.
53. Tsuda H, T Wada, Y Ito, H Uchida, H Dehari, K Nakamura et al. (2003). Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol Ther 7:354-365.
54. Conget PA and JJ Minguell. (2000). Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. Exp Hematol 28:382-390.
55. Nakamura K, Y Ito, Y Kawano, K Kurozumi, M Kobune, H Tsuda et al. (2004). Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 11:1155-1164.
56. Bergelson JM, JA Cunningham, G Droguett, EA Kurt-Jones, A Krithivas, JS Hong et al. (1997). Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1333.
57. Wickham TJ, P Mathias, DA Cheresh and GR Nemerow. (1993). Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.
58. Ito H, JJ Goater, P Tiyapatanaputi, PT Rubery, RJ O'Keefe and EM Schwarz. (2004). Light-activated gene transduction of recombinant adeno-associated virus in human mesenchymal stem cells. Gene Ther 11:34-41.
59. Yokoo N, T Saito, M Uesugi, N Kobayashi, KQ Xin, K Okuda et al. (2005). Repair of articular cartilage defect by autologous transplantation of basic fibroblast growth factor gene-transduced chondrocytes with adeno-associated virus vector. Arthritis Rheum 52:164-170.
60. Ferrari FK, T Samulski, T Shenk and RJ Samulski. (1996). Second-strand synthesis is a ratelimiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 70:3227-3234.
61. Hauck B, W Zhao, K High and W Xiao. (2004). Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction. J Virol 78:13678-13686.